Woodwardia

Woodwardia (Chain Ferns): A Comprehensive Reference on Botanical Identity, Traditional Use, Phytochemistry, and Scientific Evidence

1. Identity: Taxonomy, Botanical Description, and Common Forms

1.1 Taxonomic Classification

Woodwardia is a genus of ferns in the family Blechnaceae, in the suborder Aspleniineae (eupolypods II) of the order Polypodiales. Species are commonly known as netted-chain ferns and the genus is native to warm temperate and subtropical regions of the Northern Hemisphere. The genus was first formally described by James Edward Smith in 1793, and was named after Thomas Jenkinson Woodward. The fossil record of the genus extends to the Paleocene.

Woodwardia has traditionally been used as a "catch-all" genus for ferns in the family Blechnaceae that share a distinctive venation pattern in common — the veins on either side of the midribs anastomose to form elongate "chains." As currently understood, the genus includes 14 species and their hybrids, most native to warm temperate and subtropical areas in the Northern Hemisphere.

1.2 Medically and Scientifically Notable Species

Multiple species within the genus have attracted ethnobotanical or scientific interest. The principal species discussed in the research literature include:

• Woodwardia japonica (L.f.) Sm. — a fern of great potential as both an edible and medicinal plant, native to East Asia and widely distributed across Japan, Korea, China, Vietnam, and Thailand.
• Woodwardia unigemmata (Makino) Nakai — commonly known as the jewelled chain fern, belongs to family Blechnaceae. It is the single species of this genus found in India.
• Woodwardia radicans (L.) Sm. — known by the common names chain fern, European chain fern, and rooting chainfern, a species of fern in the family Blechnaceae, native to the Atlantic islands and southwestern Europe.
• Woodwardia fimbriata Sm. — known by the common name giant chain fern, an evergreen perennial fern species in the family Blechnaceae. It is native to western North America from British Columbia through California, including the Sierra Nevada, into Baja California.
• Woodwardia virginica (L.) Sm. — known as the Virginia chainfern, a deciduous, perennial, upright fern with long, purple-brown stalks.
• Woodwardia orientalis Sw. — a species native to East Asia, notable for the isolation of bioactive glucosides in laboratory research.

1.3 Morphological Description

Members of the genus are large ferns, with fronds growing to 50–300 cm long depending on the species. Woodwardia unigemmata, for example, is an evergreen fern with arching, bipinnately-divided fronds reaching up to 1.5 m in length. In its native habitat it grows as a forest understory plant, is terrestrial and lithophytic, grows well in beds of hill ravines, and is widely distributed throughout the Himalayan region usually between 1,200 and 2,400 m altitude. Chain ferns get their common name from the chain-like rows of oblong sori on the undersides of the pinnae.

1.4 Common Forms and Preparations

Across different species and cultural traditions, Woodwardia is used or prepared in several distinct forms:

• Decoctions of the rhizome: Decoctions of the rhizome and fronds are internally administered in traditional contexts; the dried rhizome is also used as a purgative.
• Dried and powdered rhizome: Used in traditional Chinese medicine as a component of the drug known as Gouji Guanzhong.
• Food preparations from the rhizome: Woodwardia japonica is used in China, particularly the starch in the rhizomes, which is prepared as cakes, noodles, and liquor.
• Fronds as vegetable: Young fronds of some species are harvested and cooked as a vegetable in East Asian traditions.
• Solvent extracts (laboratory/pharmacological context): Scientific studies have produced aqueous, methanol, and hexane extracts for analysis of antioxidant and antibacterial activity.
• Fiber and basketry material: The indigenous tribes of California used fibers obtained from Woodwardia fimbriata to add patterns into their baskets; fibers were obtained from the stems and dyed red using an extract from white alder before being added into baskets.

2. Traditional and Historical Use

2.1 Traditional Chinese Medicine

The rhizome of Woodwardia japonica Smith (Blechnaceae) is a traditional Chinese medicine, named Gouji Guanzhong in Chinese, used to cure flu and verminosis. Its clinical use is the same as the rhizome of Dryopteris crassirhizoma, named as Mianma Guanzhong, as recorded in the Chinese pharmacopoeia.

In traditional Chinese medicine, the rhizome has been used as one of several fern sources of a tonic material historically identified with the drug name gouji, alongside Cibotium barometz, though Woodwardia rhizomes have generally been treated as less preferred substitutes. Among Taiwanese aboriginal peoples and Hakka communities of the southern China hill country, various minor medicinal applications have been documented in ethnobotanical surveys.

In the traditional Chinese system of medicine, several ferns are recommended by native doctors. The broader context of fern use in Chinese traditional medicine is longstanding: the biomedical system and Ayurvedic systems of medicine, named Sushruta (ca. 100 AD) and Charka (ca. 100 AD), suggested the use of some ferns in the Samhita texts.

2.2 Himalayan and South Asian Traditions

Woodwardia unigemmata has a vast literature on traditional and economic uses. The decoction of rhizome and fronds is internally administered in dysentery, the dried rhizome used as a purgative, and fronds are used in skin diseases and infertility.

2.3 European Traditions (Woodwardia radicans)

Woodwardia radicans has been attributed anthelmintic and astringent properties in ethnobotanical records; a decoction of the roots has been used both internally and externally in the treatment of pain from injuries.

2.4 Indigenous North American Use (Woodwardia fimbriata)

Not only is it used in gardens, but Woodwardia fimbriata also has a history of use by the native tribes in the United States. The indigenous tribes of California used fibers obtained from Woodwardia fimbriata to add patterns into their baskets. This use was cultural and craft-oriented rather than strictly medicinal.

2.5 Food Uses in East Asia

Common products in China include dried fronds, salted fronds, packaged fronds, fern starch, fern starch noodles, fern starch cakes, and fern leaf tea. Woodwardia japonica is a fern of great potential as an edible and medicinal plant.

3. Key Constituents and Active Compounds

3.1 Phytochemical Classes Identified Across the Genus

Multiple peer-reviewed phytochemical investigations have identified a broad range of compound classes across Woodwardia species. Woodwardia unigemmata was found to contain a significant enrichment of various phytochemicals including flavonoids, terpenoids, alkaloids, carotenoids, tannins, saponins, quinones, carbohydrates, phenols, coumarins, and phlobatannins.

3.2 Specific Compounds Identified by GC-MS and Isolation Studies

A 2020 study published in the Saudi Journal of Biological Sciences using GC-MS analysis of W. unigemmata characterized the chemical profiles of three distinct solvent fractions. Investigation of the aqueous extract (AEW) revealed the existence of 26 compounds, representing 88% of the total volume, with catechol (21.96%), glycerol (20.22%), n-pentadecanoic acid (6.95%), glyceryl monoacetate (6.35%), ethyl acetimidate (5.39%), and 3-hydroxy-2,3-dihydromaltol (5.36%) as major components.

The methanol extract (MEW) showed β-sitosterol (17.39%), pentadecanoic acid (9.81%), vitamin E (7.82%), and glycerol (7.05%) as major contributors. The hexane extract (HEW) displayed a total of 15 compounds, comprising 72.42% of total fraction with γ-sitosterol (33.45%), vitamin E (10.04%), and campesterol (7.32%) as its prominent compounds.

For Woodwardia japonica, phytochemical investigation of an ethanolic extract yielded a set of structurally diverse compounds. The phytochemical investigation of the ethanolic extract of W. japonica resulted in the isolation of four sterones — including ecdysterone, achyranthesterone A, ponasterone A, and ponasteroside A — one triterpene, woodwardic acid, and two flavonoids: kaempferol-3-O-rhamnopyranoside-7-O-rhamnopyranoside and kaempferol-3-O-(4-O-acetyl)-rhamnopyranoside-7-O-rhamnopyranoside.

Two cyclohexenone glycosides were isolated from the American fern Woodwardia virginica. A new glucoside, woodorien, was isolated from W. orientalis extract, and was identified as the most potent inhibitor of type I Herpes simplex virus.

3.3 Flavonoids in Woodwardia unigemmata

Phytochemical investigation of the methanol extract of Woodwardia unigemmata resulted in the isolation of seven flavonoids, including one new flavonol acylglycoside. The structures of these compounds were elucidated on the basis of extensive spectroscopic analysis and comparison of literature data.

3.4 Quantitative Phenolic and Flavonoid Content

Maximum phenolics (873 ± 6.01 mgGAE/g dry extract) as well as flavonoids (151 ± 11.44 mgQE/g dry extract) content was found in the methanol extract of W. unigemmata, which also showed remarkable antioxidant potential (IC50 6.07 ± 1.4 µg/ml for DPPH and 768 ± 10.4 mg AAE/g dry extract for FRAP assay).

Among the Asian species, Woodwardia japonica contained the highest flavonoid content (191.7 mg/g) in a survey of ferns from Tianmu Mountain, and most ferns from Tianmu Mountain showed strong antioxidant activity. A larger 2023 study confirmed substantial variability: total flavonoid contents of W. japonica from nine main producing areas differed but were all more than 114.55 mg/g; the highest was recorded from Wuyi Mountain (Jiangxi Province) at 345.4 mg/g, and the lowest from Tianmu Mountain at 114.5 mg/g.

3.5 Phenolic Acids

A body of literature on fern phenolics is relevant to Woodwardia. Phenolic compounds are essential for plant development and play an important role in their defense mechanisms; flavonoids are the most abundant secondary metabolites, with more than 8,000 known phenolic structures. The presence of hydroxylated cinnamic acids including p-coumaric, caffeic, and ferulic acids has been documented in surveys of ferns belonging to related families, and catechol — a phenolic compound — was the dominant identified component in the aqueous extract of W. unigemmata.

3.6 Phytosterols and Sterols

The presence of β-sitosterol and γ-sitosterol in significant proportions of the methanol and hexane extracts of W. unigemmata is consistent with the phytosterol profile of many Blechnaceae ferns. Campesterol was similarly identified in the hexane fraction. These phytosterols are well-characterized plant compounds known from broader nutritional and pharmacological literature.

4. Scientific Evidence by Area of Use

4.1 Antioxidant Activity

Evidence strength: In vitro / laboratory only — no clinical human studies.

The most consistently documented pharmacological property of Woodwardia species in the peer-reviewed literature is antioxidant activity, assessed exclusively by in vitro assays.

A study published in the Saudi Journal of Biological Sciences (PMC7376181) elucidated the antioxidant and antibacterial activity of W. unigemmata along with chemical characterization using aqueous, methanol, and hexane extracts. Antioxidant activities were tested using DPPH and FRAP assays, total phenolic and flavonoid content by Folin-Ciocalteu and aluminum chloride methods, respectively.

The results showed that polar extracts had remarkable antioxidant potential, while the non-polar extract showed significant antibacterial activity. The methanol extract showed particularly high activity: an IC50 of 6.07 ± 1.4 µg/ml (DPPH assay) indicates potent radical-scavenging capacity under laboratory conditions. GC-MS reports indicated that this traditionally useful fern species can be an excellent source of biologically active compounds.

For W. japonica, flavonoid and antioxidant activity of W. japonica from different sites were found to differ; the cause of these differences remained unclear, restricting the utilization of the species. A 2023 study published in Molecules examined flavonoid and antioxidant activity of W. japonica from nine different regions using colorimetric assay with UV-VIS spectrophotometry and HPLC-ESI-TOF-MS, evaluating the effects of climate factors on flavonoids and antioxidant activities by mathematical modeling and statistical methods. Extracts from W. japonica showed the highest ABTS scavenging activity among the ferns tested in that survey.

No human clinical trials on the antioxidant effects of Woodwardia supplementation have been identified in the published literature. All evidence is in vitro.

4.2 Antibacterial Activity

Evidence strength: In vitro only — no clinical human studies.

Several in vitro studies have tested Woodwardia extracts against bacterial pathogens. Antibacterial activity of W. unigemmata was analyzed against six plant and four animal pathogenic bacteria using the disc diffusion assay.

Results from this study showed mixed outcomes depending on extract type: maximum inhibition (15 ± 0.9 mm) was observed for the hexane extract (HEW) against R. solanacearum, followed by the aqueous extract (AEW) against A. tumefaciens and X. phaseoli (11 ± 0.3 mm each); MEW was found positive only against A. tumefaciens; a significant minimum inhibitory concentration (MIC) value was observed for AEW against L. monocytogenes (10 mg/ml).

A more recent 2025 study in PLOS ONE (PMC11734996) found that extracts prepared in organic solvents showed strong antibacterial activity against P. aeruginosa (chloroform: 13.66±0.88 mm; methyl alcohol: 13.33±1.66 mm) and S. aureus (chloroform: 15±0.57 mm; methyl alcohol: 17.66±0.33 mm). These results suggest that W. unigemmata contains numerous bioactive phytochemicals and can be useful as a drug against MDR bacterial strains. However, these results are purely from laboratory disc-diffusion assays, and no clinical relevance to human infection has been established.

4.3 Antiviral Activity

Evidence strength: Preliminary in vitro / historical — no clinical human studies.

The most specific antiviral finding in the Woodwardia genus involves Woodwardia orientalis. A new glucoside, woodorien, was isolated from W. orientalis extract and was identified as the most potent inhibitor of type I Herpes simplex virus. This finding, attributed to Xu et al. (1993) in the scientific literature, has been cited in subsequent reviews but does not represent current clinical evidence; it is based on early in vitro screening.

The rhizome of Woodwardia orientalis was also disclosed in patent literature as antiherpesviral, antipolioviral, anti-measles virus, anti-varicella-zoster virus, anti-cytomegalovirus (CMV), and anti-DNA and anti-RNA virus agents. These disclosures are based on early laboratory findings and have not been confirmed in human clinical trials.

4.4 Multidrug Resistance (MDR) Reversal Activity

Evidence strength: Preliminary in vitro — cell-line studies only, no clinical data.

A study published in Molecules (2017; PMC6152408) investigated the flavonoids of Woodwardia unigemmata for their ability to reverse multidrug resistance in cancer cells. The multidrug resistance (MDR) reversing activity was evaluated for the isolated compounds using doxorubicin-resistant K562/A02 cells model; compound 6 showed comparable MDR reversing effect to verapamil.

This finding has been acknowledged in subsequent reviews of natural product pharmacology: a flavonol acylglycoside isolated from Woodwardia unigemmata, compound 6, showed comparable multidrug resistance (MDR) reversal effects to verapamil (a P-glycoprotein inhibitor) in doxorubicin-resistant human leukemia cell line K562/A02 cells, suggesting that it may serve as a sensitizing agent. This is a cell-line study with no translation to human clinical outcomes established.

The interaction between the compounds and bovine serum albumin (BSA) was also investigated by spectroscopic methods including steady-state fluorescence, synchronous fluorescence, circular dichroism (CD) spectroscopies, and molecular docking approach; the experimental results indicated that the seven flavonoids bind to BSA by static quenching mechanisms. This has implications for understanding the bioavailability and pharmacokinetic behavior of these flavonoids, but remains preclinical.

4.5 Anticancer Activity

Evidence strength: Preliminary in vitro / cell-line — no clinical human studies.

A 2025 study published in PLOS ONE (PMC11734996) investigated the anticancer potential of W. unigemmata. Anticancer potential was determined against gastric cancer and normal gastric epithelial cells using CCK8 and colony formation assays; W. unigemmata was found to have significant enrichment of various phytochemicals including flavonoids, terpenoids, alkaloids, carotenoids, tannins, saponins, quinones, carbohydrates, phenols, coumarins, and phlobatannins. Phytochemical enrichment does not by itself establish clinical anticancer efficacy; all activity data in this study remains in vitro.

4.6 Anthelmintic and Antiparasitic Properties

Evidence strength: Ethnobotanical record only — no modern controlled studies.

The rhizome of Woodwardia japonica Smith is a traditional Chinese medicine used to cure flu and verminosis. The antiparasitic attribution is based solely on historical use records; no controlled clinical or animal studies verifying anthelmintic activity specific to Woodwardia were identified in the peer-reviewed literature.

4.7 Flavonoid Content and Nutraceutical Potential

Evidence strength: Analytical chemistry — no clinical efficacy data.

Flavonoids have been used in the development of nutraceuticals and drugs because they have biological activities related to anti-inflammatory potential, cardioprotective, and anticancer effects, among others. The exceptional measured flavonoid concentrations in Woodwardia japonica — up to 345.4 mg/g in some specimens — make it a candidate for nutraceutical development in academic literature, though this has not yet been translated into standardized supplement products with clinical trial validation.

5. Body Systems and Health Areas Associated with Woodwardia

• Gastrointestinal system: Traditional use in dysentery (rhizome decoction, W. unigemmata); use of W. japonica rhizome in traditional Chinese medicine for verminosis; use as a purgative (dried rhizome).
• Dermatological / skin: Fronds of W. unigemmata used in skin diseases in traditional Himalayan practice.
• Reproductive health: Fronds of W. unigemmata have been used in the context of infertility in traditional practices. No modern clinical data support this use.
• Antimicrobial defense: In vitro antibacterial and antiviral properties demonstrated across multiple species in laboratory studies.
• Musculoskeletal / pain: A decoction of the roots of W. radicans has been used both internally and externally in the treatment of pain from injuries.
• Oncology (preclinical interest): MDR reversal activity demonstrated in leukemia cell lines; anticancer potential assessed in gastric cancer cell lines, both at the in vitro stage only.
• Respiratory / infectious disease: Traditional use of W. japonica rhizome for influenza-like illness; in vitro antiviral activity against Herpes simplex virus type I from W. orientalis.

6. Dosage Forms and Reported Dosages

No standardized supplement dosage for Woodwardia preparations has been established in pharmacopeial monographs or clinical guidelines. Dosage information in the literature is limited to contexts of traditional use and laboratory study concentrations:

• Traditional internal decoction: The literature references decoction of rhizome and fronds as an internally administered preparation in traditional Himalayan medicine, without specifying standardized quantities.
• Laboratory extract concentrations: The ethanolic extracts of W. unigemmata were tested at concentrations of 500 µg, 1,000 µg, and 2,000 µg in the 2025 anticancer cell-line study.
• MIC value reported: A significant minimum inhibitory concentration (MIC) value was observed for the aqueous extract of W. unigemmata against L. monocytogenes at 10 mg/ml in disc-diffusion assays.
• Silver nanoparticle preparations: Extracts in different organic and inorganic solvents were prepared, and silver nanoparticles were prepared using the green synthesis method in the 2025 study, representing a laboratory formulation with no established human dosage.

No human clinical trial dose-finding data for any Woodwardia preparation have been identified in the published literature.

7. Safety Considerations

7.1 Thiaminase Content

Although no reports of toxicity specific to Woodwardia radicans have been found, a number of ferns contain carcinogens, so some caution is advisable. Many ferns also contain thiaminase, an enzyme that depletes vitamin B complex. In small quantities this enzyme will do no harm to people eating an adequate diet rich in vitamin B, though large quantities can cause severe health problems. The enzyme is destroyed by heat or thorough drying, so cooking the plant will remove the thiaminase.

This applies to ferns broadly, including the genus Woodwardia, since thiaminase has been documented across the Blechnaceae family. Raw or inadequately processed consumption of large quantities of any Woodwardia species carries a theoretical risk of thiamine (vitamin B1) deficiency.

7.2 Potential Carcinogen Concerns in Ferns (General Genus Context)

The literature notes that some fern species contain carcinogenic compounds — notably ptaquiloside in bracken ferns (Pteridium spp.). While Woodwardia is a distinct genus, no specific carcinogenic compound analogous to ptaquiloside has been isolated from Woodwardia and confirmed in peer-reviewed sources. The general caution regarding fern carcinogens is appropriately noted in botanical databases for the genus but lacks species-specific quantified risk data.

7.3 Absence of Human Toxicological Data

No controlled human toxicology or safety studies specific to any Woodwardia species were identified in peer-reviewed literature. There are no established no-observed-adverse-effect levels (NOAELs) or tolerable upper intake levels for any prepared form of Woodwardia.

7.4 Drug Interactions

No drug interaction data specific to Woodwardia preparations were identified in the peer-reviewed scientific or pharmacological literature. Given the presence of flavonoids in appreciable concentrations (particularly in W. japonica and W. unigemmata), and given documented interactions of flavonoids as a class with cytochrome P450 enzymes and P-glycoprotein, this area warrants future research but cannot be specifically characterized for Woodwardia based on available evidence.

7.5 Regulatory Status

No Woodwardia species appears in the monographs of the German Commission E, ESCOP, WHO monographs on selected medicinal plants, or the EFSA register of botanical ingredients at the time of this review. The NIH Office of Dietary Supplements and NCCIH do not maintain a specific fact sheet or health advisory on Woodwardia. The genus accordingly lacks the regulatory assessment frameworks applied to more widely studied botanical dietary supplements.

8. Overall Evidence Assessment

The scientific study of Woodwardia as a medicinal or dietary supplement ingredient is at an early, predominantly preclinical stage. The genus has genuine ethnobotanical depth — particularly in East Asian and Himalayan traditional medicine — and laboratory phytochemical work has confirmed the presence of biologically active flavonoids, phytosterols, phenolics, and ecdysteroids across multiple species. Specific compounds such as woodwardic acid, kaempferol glycosides, woodorien, and flavonol acylglycosides represent potentially interesting pharmacological leads. However:

• All bioactivity data (antioxidant, antibacterial, antiviral, MDR reversal, anticancer) derive from in vitro or cell-line experiments.
• No randomized controlled trials, controlled human studies, or systematic reviews specific to Woodwardia supplementation have been published.
• Dosages for human therapeutic use have not been established.
• Safety profiling in humans is absent from the literature.

GC-MS reports indicate that this traditionally useful fern species can be an excellent source of biologically active compounds, and the same observation applies across the genus. The translation of these laboratory-level findings to validated human health applications remains a subject for future research.

References

• Wikipedia: Woodwardia (genus overview, taxonomy, fossil record)
• Wikipedia: Woodwardia fimbriata (giant chain fern)
• Takuli P, et al. "Phytochemical profiling, antioxidant and antibacterial efficacy of a native Himalayan Fern: Woodwardia unigemmata (Makino) Nakai." Saudi Journal of Biological Sciences, 2020. PMC7376181.
• Ma R, et al. "Interaction of Flavonoids from Woodwardia unigemmata with Bovine Serum Albumin (BSA): Application of Spectroscopic Techniques and Molecular Modeling Methods." Molecules, 2017. PMC6152408.
• Shah SA, et al. "Phytochemical analysis and biological activities of solvent extracts and silver nanoparticles obtained from Woodwardia unigemmata (Makino) Nakai." PLOS ONE, 2025. PMC11734996.
• Wang X, et al. "Elucidating Flavonoid and Antioxidant Activity in Edible and Medicinal Herbs Woodwardia japonica (L.f.) Sm. Based on HPLC-ESI-TOF-MS and Artificial Neural Network Model." Molecules, 2023. PMC9964229.
• Sett S, et al. "A review of the use of pteridophytes for treating human ailments." PMC5833325.
• PMC6099919: Special Issue — Natural Products: Anticancer and Beyond (includes citation of W. unigemmata MDR data).
• Phytochemical Investigation of Woodwardia japonica (ResearchGate, includes ecdysterone, woodwardic acid, kaempferol glycoside data).
• Phytochemical profiling, antioxidant and antibacterial efficacy of a native Himalayan Fern: Woodwardia unigemmata (ScienceDirect).
• Analysis of flavonoids and antioxidants in extracts of ferns from Tianmu Mountain (ScienceDirect, 2016).
• USDA Forest Service FEIS: Woodwardia virginica (Virginia chainfern).
• Plants For A Future (PFAF): Woodwardia radicans — ethnobotanical and safety data.
• Practical Plants: Woodwardia radicans (Chain Fern) — thiaminase and safety notes.
• Plant Delights Nursery: Woodwardia and Associated Species (genus overview and species list).
• Plants of the World Online (Kew Science): Woodwardia japonica (L.f.) Sm.
• PubMed: Shah SA et al. 2025 — Phytochemical analysis and biological activities of W. unigemmata (PMID 39813178).